Rossari Biotech Limited (BOM:543213)
India · Delayed Price · Currency is INR 523.75
-10.35 (-1.94%)
At close: Feb 13, 2026
Rossari Biotech Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | 1,364 | 1,307 | 1,073 | 976.74 | 802.2 |
Depreciation & Amortization | 670.73 | 603.9 | 627.6 | 480.01 | 227.9 |
Other Amortization | - | - | 1.71 | 0.54 | 0.39 |
Loss (Gain) From Sale of Assets | 0.69 | -18.78 | -2.83 | -6.38 | -4.32 |
Loss (Gain) From Sale of Investments | -18.98 | -25.18 | -2.71 | -14.18 | -22.94 |
Loss (Gain) on Equity Investments | -9.78 | -1.75 | -9.57 | -15.54 | -4.11 |
Stock-Based Compensation | 0.68 | 6.87 | 9.43 | 18.31 | 16.27 |
Provision & Write-off of Bad Debts | 29.48 | 36.02 | 20.15 | 8.86 | 0.71 |
Other Operating Activities | 67.61 | 93.06 | 77.54 | -34.31 | -55.38 |
Change in Accounts Receivable | -853.93 | -1,126 | -286.03 | -425.28 | -404.5 |
Change in Inventory | -727.54 | -938.48 | 7.32 | -481.85 | -320.25 |
Change in Accounts Payable | 851.69 | 496.34 | 0.4 | -213.34 | 241.7 |
Operating Cash Flow | 1,374 | 432.55 | 1,516 | 293.58 | 477.67 |
Operating Cash Flow Growth | 217.75% | -71.46% | 416.24% | -38.54% | -15.95% |
Capital Expenditures | -1,585 | -1,313 | -328.76 | -382.25 | -580.84 |
Sale of Property, Plant & Equipment | 0.21 | 54.94 | 16.85 | 19.11 | 21.86 |
Cash Acquisitions | -3.15 | -177.33 | -985.31 | -3,475 | -43.39 |
Investment in Securities | -256.18 | 376.04 | -534.37 | 799.57 | 195.31 |
Other Investing Activities | 7.29 | 27.04 | 22.65 | 49.69 | 35.27 |
Investing Cash Flow | -1,837 | -1,032 | -1,809 | -2,989 | -371.79 |
Short-Term Debt Issued | 272.46 | 434.8 | 205.85 | - | - |
Long-Term Debt Issued | 934.79 | - | 449.16 | - | - |
Total Debt Issued | 1,207 | 434.8 | 655.01 | - | - |
Short-Term Debt Repaid | - | - | - | -48.12 | -270.52 |
Long-Term Debt Repaid | -416.09 | -123.93 | - | - | -339.6 |
Total Debt Repaid | -416.09 | -123.93 | - | -48.12 | -610.12 |
Net Debt Issued (Repaid) | 791.16 | 310.87 | 655.01 | -48.12 | -610.12 |
Issuance of Common Stock | 50.67 | 38.45 | 42.12 | 3,015 | 426.53 |
Common Dividends Paid | -27.65 | -27.58 | -27.53 | -27.53 | -25.38 |
Other Financing Activities | -165.17 | -159.89 | -61.05 | -21.5 | -36.95 |
Financing Cash Flow | 649.01 | 161.85 | 608.55 | 2,918 | -245.92 |
Foreign Exchange Rate Adjustments | 3.83 | -2.54 | 2.02 | - | 0.01 |
Net Cash Flow | 190.32 | -440.28 | 317.21 | 222.69 | -140.03 |
Free Cash Flow | -210.69 | -880.28 | 1,187 | -88.67 | -103.17 |
Free Cash Flow Margin | -1.01% | -4.81% | 7.17% | -0.60% | -1.45% |
Free Cash Flow Per Share | -3.81 | -15.91 | 21.44 | -1.61 | -1.99 |
Cash Interest Paid | 165.17 | 159.89 | 61.05 | 21.5 | 38.95 |
Cash Income Tax Paid | 592.04 | 538.75 | 477.77 | 501.24 | 313.48 |
Levered Free Cash Flow | -465.62 | -1,290 | 1,088 | -579.33 | -233.84 |
Unlevered Free Cash Flow | -354.3 | -1,169 | 1,227 | -500.23 | -215.14 |
Change in Working Capital | -729.78 | -1,568 | -278.31 | -1,120 | -483.05 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.